Position in RLAY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$261,397
-$16,914 QoQ
Shares Held
13,971
-50.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#175
of 256 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fiduciary Trust Co holds $29,735,828 across 28 Biotechnology names. RLAY ranks #22 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,400 | $9,636,561 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,318 | $5,186,605 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
17,991 | $3,369,353 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
8,416 | $2,028,002 | |
| 5 | VYGR |
Voyager Therapeutics, Inc.
|
334,397 | $1,170,389 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
2,471 | $781,057 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
8,537 | $635,835 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
7,399 | $586,666 |
All Filings in RLAY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $261,397 | 13,971 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $278,311 | 27,971 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $236,634 | 27,971 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $146,008 | 27,971 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $96,779 | 27,971 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $73,284 | 27,971 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $115,240 | 27,971 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $198,034 | 27,971 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $182,370 | 27,971 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $232,159 | 27,971 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $307,960 | 27,971 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $235,236 | 27,971 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $351,315 | 27,971 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $460,682 | 27,971 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $417,886 | 27,971 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $625,711 | 27,971 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $468,514 | 27,971 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $837,172 | 27,971 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $858,989 | 27,971 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $881,925 | 27,971 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,023,458 | 27,971 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $966,957 | 27,971 | Shares | Sole | 2021-05-19 | |
| No filing history on record for this holder in this stock. | ||||||